Publications by authors named "Stuart Deoraj"

5 Publications

  • Page 1 of 1

Prevalence, Mechanisms, Treatment, and Complications of Hypertension Postliving Kidney Donation.

Biomed Res Int 2021 4;2021:5460672. Epub 2021 Feb 4.

Azienda Ospedaliera San Camillo Forlanini, Rome, Italy.

Living kidney donors represent a unique population of patients. Potential donors are selected based on the belief that their preoperative fitness is likely to mitigate the risks of long- and short-term harm following uninephrectomy. Studies performed on postdonation outcomes have largely focused on mortality and the risk of end-stage renal failure, but have also investigated secondary outcomes such as cardiovascular morbidity and hypertension. It has been postulated that hypertension is a possible outcome of living kidney donation. A variety of studies have been conducted to investigate the prevalence, epidemiology, mechanisms, treatment strategies, and long-term ramifications of hypertension postdonation. These studies are heterogeneous in their population, design, methodology, and outcome measures and have presented contradicting outcomes. Additionally, the absence of a well-matched control group has made it challenging to interpret and generalise the reported findings. As such, it is not possible to definitively conclude that hypertension occurs at a higher rate among donors than the general population. This article will review the evidence of postdonation hypertension prevalence, mechanisms, treatment, and complications.
View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.1155/2021/5460672DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884138PMC
June 2021

Multifactorial aggressive and reversible cardiomyopathy in systemic lupus erythematosus.

Br J Hosp Med (Lond) 2020 Apr 14;81(4):1-4. Epub 2020 Apr 14.

Department of Cardiology, Wexham Park Hospital, Frimley Health NHS Foundation Trust, Slough, UK.

View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.12968/hmed.2020.0053DOI Listing
April 2020

Audit of the prevalence and investigation of iron deficiency anaemia in patients with heart failure in hospital practice.

Postgrad Med J 2020 Apr 15;96(1134):206-211. Epub 2019 Nov 15.

Department of Cardiology, Wexham Park Hospital, Frimley Health NHS Foundation Trust, Slough, Berkshire, United Kingdom

Purpose Of The Study: Iron deficiency anaemia (IDA) is associated with increased morbidity and mortality in heart failure patients. The aim of our audit was to evaluate the current practice in diagnosis and assessment of IDA in patients admitted with heart failure.

Study Design: We conducted a retrospective audit of patients admitted to our hospital between January 2017 and June 2017 with a diagnosis of heart failure, and obtained data regarding each patient's demographics and anaemic status. We also conducted a qualitative survey to assess healthcare professionals' ability to diagnose IDA, and their knowledge of iron replacement in heart failure patients.

Results: Our audit identified 218 heart failure patients, nearly two-thirds (n=138, 63.3%) of which were anaemic. Of the 138 anaemic patients, only 40 had a full haematinic screen compared with 98 who had incomplete investigations (29% vs 71%, p=0.007). Iron studies were the most commonly performed haematinic investigation (n=87, 63%), and over half of these patients were iron deficient (n=49, 56.3%). Only 12 (24.5%) iron deficient patients were prescribed oral iron therapy, while 37 (75.5%) were left without iron replacement (X=12.8, p=0.0003). Our survey demonstrated a lack of awareness among healthcare professionals with only 19.7% of participants being able to correctly define anaemia and 9.1% being aware of guidelines regarding treatment of IDA.

Conclusion: Many patients admitted to hospital with heart failure also have a concomitant diagnosis of anaemia. The aetiology of the underlying anaemia is often poorly investigated, and where IDA is identified it is poorly treated.
View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.1136/postgradmedj-2019-136867DOI Listing
April 2020

Complete Regression of Primary Cardiac Lymphoma With Dose-Attenuated R-CVP Chemotherapeutic Regimen.

JACC Case Rep 2019 Oct 4;1(3):332-336. Epub 2019 Sep 4.

Departments of Cardiology and Medicine, Wexham Park Hospital, Frimley Health NHS Foundation Trust, Slough, Berkshire, United Kingdom.

An elderly man was found to have a large right atrioventricular mass and pericardial effusion. He was diagnosed and treated as having primary cardiac lymphoma. A dose-attenuated chemotherapy regimen of rituximab, cyclophosphamide, vincristine, and prednisolone, with a cytoreductive pre-phase, afforded complete regression of disease with resolution of the patient's symptoms, and without deterioration in cardiac function or immunosuppression. The patient remains well 12 months after presentation. ().
View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaccas.2019.06.033DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8289086PMC
October 2019

Emphysematous pyelonephritis: outcomes of conservative management and literature review.

BMJ Case Rep 2018 Sep 12;2018. Epub 2018 Sep 12.

Department of Cardiology, Frimley Health Foundation Trust, Slough, Berkshire, UK.

Emphysematous pyelonephritis (EPN) is a rare, necrotising infection of the renal parenchyma, predominantly associated with infection and unless promptly recognised and dealt with, it carries a poor prognosis. The current treatment is one of antimicrobial therapies together with nephrectomy in a majority of patients. We report an elderly man with multiple comorbidities with a diagnosis of EPN whose condition improved with antimicrobial and supportive therapy, and no surgical intervention was required.
View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.1136/bcr-2018-225931DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6144252PMC
September 2018
-->